Weight Loss
20 min read
Written by Holly Hurst
Published: Nov 25, 2024
Medically Reviewed by Dr. Paul Hetrick
Tirzepatide is the active ingredient in 2 prescription medications. Mounjaro for controlling blood sugar levels in people with type 2 diabetes mellitus. And Zepbound for helping people with obesity and overweight with weight loss and weight management. It’s also available as compounded tirzepatide.
If your provider recommends any form of tirzepatide for you, you want to know what tirzepatide side effects are. You also want to know about its warnings, contraindications, and potential drug interactions.
In this article, we cover it all, so you can quickly recognize potential problems and help make your treatment safer and outcome more effective.
If you’re struggling with weight loss, convenient, online treatment is available. Find a provider on Klarity Health today.
Tirzepatide is the active ingredient in the brand-name prescription medications Zepbound and Moujaro, and compounded tirzepatide, available from compounding pharmacies.
Zepbound is made by Eli Lilly and approved by the U.S. Food and Drug Administration (FDA) for the treatment of obesity in adults with a body mass index (BMI) of 30 or higher. It’s also FDA-approved for overweight people with a BMI of 27 or higher who have at least 1 weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol, Either group must combine using Zepbound with diet and exercise.
Moujaro is also made by Eli Lilly and FDA-approved to help improve glycemic control when used with diet and exercise for people with type 2 diabetes. It should also be combined with diet and exercise.
Compounded tirzepatide isn’t FDA-approved. But when purchased from a reputable compounding pharmacy, the pharmacy will be FDA-regulated and use pharmaceutical-grade tirzepatide in the medication.
Tirzepatide is a glucagon-like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP) dual agonist receptor medication. It mimics 2 natural hormones in the body GLP-1 and GIP. GLP-1 and GIP affect glucagon secretion, promote insulin secretion, and slow down how fast food leaves your stomach. By mimicking the natural hormones, medications with tirzepatide help improve blood sugar control and make you want to eat less and can lead to weight loss.
People who took Zepbound in clinical trials lost up to 20.9% of their body weight in 72 weeks.
Those benefits can come at a cost though, in the form of side effects.
Tirzepatide as the active ingredient in Zepbound and Mounjaro and compounded tirzepatide can cause side effects. The most common include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach pain nausea.
It’s during clinical trials — done as part of getting medications approved by the FDA — where issues with a medication and adverse effects are identified, which include:
Compounded medications, like compounded tirzepatide, aren’t tested in clinical trials, but their side effects are typically similar to those of brand-name drugs. This means they could have similar risks and should be used just as carefully.
Because compounded medications are customized or made in small batches they may include ingredients not found in brand-name drugs. Those ingredients may have side effects of their own as well.
Before you begin taking Zepbound, Mounjaro, or compounded tirzepatide, it’s important to know about potential warnings, contraindications, possible drug interactions, and possible side effects.
An FDA boxed warning, once called a black box warning because it’s shown in a black box on a medication label, is the FDA’s strongest warning for a drug. It means the medication may have serious risks.
All GLP-1/GIP and GLP-1 receptor agonist medications, including Zepbound, have a boxed warning. This warning is because in animal studies on rats and mice, test animals developed thyroid tumors when given these medications. It’s not clear if humans develop tumors from taking Zepbound.
If you have a personal or family history of thyroid cancer, particularly medullary thyroid carcinoma (MTC, a type of thyroid cancer) or multiple endocrine neoplasia syndrome type 2 (MEN2), make sure to tell your healthcare provider. Your provider may choose to measure your serum calcitonin level. A high level may indicate MTC. Together, you can consider the risks and benefits of taking Zepbound.
Zepbound, Mounjaro, and compounded tirzepatide shouldn’t be taken by people with:
Always consult with a healthcare professional to determine if a medication is safe for you.
Tirzepatide can interact with other medications you take and change how tirzepatide or other medications work or increase possible side effects.
When starting Zepbound, Mounjaro, or compounded tirzepatide, tell your provider if you’re taking insulin or an insulin secretagogue, such as sulfonylurea. Because tirzepatide reduces blood sugar levels, you may need to lower the dose of other diabetes medications to reduce the possibility of hypoglycemia (low blood sugar).
And because Zepbound, Mounjaro, and compounded tirzepatide can slow down how fast your stomach empties, they might affect how well other oral medications are absorbed. Be sure to give your provider a complete list of all medications you’re taking, including hormone-based oral birth control pills.
Your provider may recommend you switch to a non-pill contraceptive method or add a barrier method, like a condom, for 4 weeks after starting Zepbound, Mounjaro, or compounded tirzepatide and for 4 weeks each time you increase your tirzepatide dose.
The most common side effects of Zepbound including some that only happened to a small percentage of trial participants are shown in the table below.
Common side effect | Affected % of placebo group | Affected % of Zepbound group taking 5, 10, or 15 mg doses |
Nausea | 8 | Up to 29 |
Diarrhea, which can include frequent bowel movements | 8 | Up to 23 |
Vomiting | 2 | Up to 13 |
Constipation, which may include hard stools | 5 | Up to 17 |
Abdominal pain | 5 | Up to 10 |
Dyspepsia | 4 | Up to 10 |
Injection site reactions | 2 | Up to 8 |
Fatigue | 3 | Up to 7 |
Hypersensitivity reactions | 3 | Up to 5 |
Eructation (belching) | 1 | Up to 5 |
Hair loss | 1 | Up to 5 |
Gastroesophageal reflux disease (GERD), aka acid reflux or heartburn | 1 | Up to 5 |
Flatulence | 2 | Up to 4 |
Abdominal distension | 2 | Up to 4 |
Dizziness | 2 | Up to 4 |
Hypotension | 0 | Up to 2 |
Dysesthesia or dysgeusia (an abnormal or unpleasant sense of taste) | 0.0 to 0.1 | Up to 0.4 |
Table 1: Most common potential side effects of Zepbound in clinical trials.
Taking any medication can sometimes cause serious side effects, but these are rare. In clinical trials and post-marketing data, less than 10% of people who take Zepbound experienced serious side effects. But, when they did happen, they were sometimes dangerous. Serious side effects can lead to hospital stays, cause permanent harm or disability, lead to birth defects, or even be life-threatening.
Serious side effect | Affected % of placebo group | Affected % of Zepbound group taking 5, 10, or 15 mg doses |
Acute kidney injury or failure: often related to dehydration from severe gastrointestinal issues | 0.2% | 0.5% |
Acute gallbladder disease including cholelithiasis, cholecystitis, and cholecystectomy | 0.2 to 1.1% | 0.2 to 1.1% cholelithiasis occurred most frequently |
Inflammation of the pancreas (pancreatitis) | 0.2% | 0.2% |
Hypoglycemia or low blood sugar | 1.3% | 4.2% |
Increased heart rate | Not reported | Not reported |
Serious allergic reaction | 0% | 0.1% |
Diabetic retinopathy complications or new vision problems in people with type 2 diabetes | Not reported | Not reported |
Pulmonary aspiration during general anesthesia or deep sedation | Not reported | Not reported |
Depression or suicidal thoughts | Not reported | Not reported |
Table 2: Serious side effects of Zepbound in clinical trials and in post-marketing data.
If you notice any of these side effects, contact your provider immediately. And consider reporting negative side effects — serious or common — to the FDA by visiting MedWatch or calling 1-800-FDA-1088.
Zepbound and Mounjaro are relatively new drugs and there’s not a lot of data about long-term effects yet. Some potential long-term side effects include pancreatitis (which is inflammation of the pancreas) and kidney issues, though these are rare.
The SURMOUNT-1 study looked at the safety and efficacy of tirzepatide for obesity over 176-weeks (3+ years) and found small numbers of negative longer-term effects. It also found some positive effects like a return to normal blood sugar levels in more of the participants who started the study with prediabetes and took tirzepatide compared to those on placebo.
The study found that up to 81.8% of participants had at least one negative side effect. Four participants had pancreatitis, but none severe. More participants on tirzepatide than the placebo had cholecystitis and acute cholecystitis (inflammation of the gall bladder with or without gallstones) but the overall incidence was low. A small number of participants taking tirzepatide compared to the placebo also had cardiac disorders and renal (kidney) issues. Overall, the trial didn’t identify risks or side effects not seen in shorter studies.
When taking Zepbound, Mounjaro, or compounded tirzepatide, you take it as a once-a-week self-injection under the skin usually in your belly, upper thigh, or back of your upper arm. If you don’t want to inject yourself, you can have someone else inject you, usually in the back of your upper arm.
Zepbound and Mounjaro come in pre-filled single-dose pens. Tirzepatide doses include 2.5, 5.0, 7.5, 10, 12.5, and 15 milligrams per 0.5 milliliters. Your provider will have you start at the smallest dose and increase your dose typically every 4 weeks until you reach your ideal maintenance dose.
Your maintenance dose can be anywhere from 5.0 to 15 milligrams a week depending on how well your body tolerates it and how well it works for your needs.
Compounded tirzepatide will come in a vial and not a pen. You’ll use a separate needle to inject yourself. The dosages will be roughly the same as for Zepbound or Mounjaro.
If you miss a dose of Zepbound, Mounjaro, or compounded tirzepatide, take it as soon as you remember, as long as it’s not too close to your next scheduled dose. This helps keep a steady level of the medicine in your body so it works best. If you miss a dose, here’s what to do:
Refrigerate Zepbound, Mounjaro at 36°F to 46°F (2°C to 8°C). Store compounded tirzepatide per the instructions from your pharmacy. If you need to, you can store each pen or vial at room temperature, but not at a temperature above 86°F (30°C), for up to 21 days.
Once your medication reaches room temperature, don’t refrigerate it again. Instead, keep it at room temperature and throw it out if you don’t use it within 21 days. Never freeze tirzepatide. And don’t use it if it becomes frozen.
Also keep it in its original box or a cabinet or closet to protect it from light exposure.
The following tips may help reduce or minimize your side effects if you take Zepbound, Mounjaro, or compounded tirzepatide. You can also talk to your healthcare provider about ways to prevent or reduce the side effects.
Keep track of how you feel and note any side effects you experience. Sharing this information with your provider can help them provide the best advice. Remember, each person’s body reacts differently, so what works for one person might not work for another. Always prioritize your health and seek professional advice when needed.
If you’re looking for help with weight loss, Klarity Health can help you find an independent, licensed healthcare provider to help you meet your goals. Find a provider today and get the affordable, caring support you deserve.
*Appointments are generally available within 24 hours. Free initial consultations are available only with select providers. Prescriptions, particularly for controlled substances, may require an in-person evaluation depending on the state of residence and current federal regulations.
The information provided in this article is for educational purposes only and should not be construed as medical advice. Always seek the guidance of a qualified healthcare professional with any questions or concerns you have regarding your health. Providers on Klarity Health are independent practitioners with clinical autonomy. Nothing in this article is intended to diagnose or treat any condition, including guaranteeing prescription medication of any kind or dosage. Not all providers on Klarity Health prescribe all medications, particularly medications that are controlled substances.
If you’re having a mental health crisis or experiencing a psychiatric emergency, it’s crucial to seek immediate help from a mental healthcare professional, such as a psychiatrist, psychologist, or therapist. You can also call your local emergency services, visit your nearest emergency room, or contact a crisis hotline, such as the National Suicide Prevention Lifeline, by calling or texting 988 or dialing the Lifeline’s previous phone number, 1-800-273-TALK (1-800-273-8255) in the U.S.
Get free, credible health and wellness tips from Klarity Health
By clicking the button above, you agree to our Terms & Conditions and Privacy Policy.